Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. 薬物名（臨床試験情報から抽出） DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY 指定難病告示番号
10,5 mg Fingolimod
(Gilenya (TN))		1件: Fingolimod (Gilenya)1件: Fingolimod (Gilenya (TN)) 💬 1件: S1PR1 💬 3件: FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬1件: 13 💬
2FINGOLIMOD
(Gilenya (TN))		1件: Fingolimod (Gilenya)1件: Fingolimod (Gilenya (TN)) 💬 1件: S1PR1 💬 3件: FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬3件: 13, 14, 156 💬
3Fingolimod (FTY720)
(Gilenya (TN))		1件: Fingolimod (Gilenya)1件: Fingolimod (Gilenya (TN)) 💬 1件: S1PR1 💬 3件: FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬2件: 13, 156 💬
4Fingolimod 0.5 mg
(Gilenya (TN))		1件: Fingolimod (Gilenya)1件: Fingolimod (Gilenya (TN)) 💬 1件: S1PR1 💬 3件: FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬1件: 13 💬
5Fingolimod 0.5mg
(Gilenya (TN))		1件: Fingolimod (Gilenya)1件: Fingolimod (Gilenya (TN)) 💬 1件: S1PR1 💬 3件: FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬1件: 13 💬
6Fingolimod 1.25 mg
(Gilenya (TN))		1件: Fingolimod (Gilenya)1件: Fingolimod (Gilenya (TN)) 💬 1件: S1PR1 💬 3件: FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬1件: 13 💬
7FINGOLIMOD HYDROCHLORIDE
(Gilenya (TN))		1件: Fingolimod (Gilenya)1件: Fingolimod (Gilenya (TN)) 💬 1件: S1PR1 💬 3件: FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬2件: 13, 14 💬
8Gilenya1件: Fingolimod (Gilenya)1件: Fingolimod (Gilenya (TN)) 💬 1件: S1PR1 💬 3件: FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬3件: 2, 13, 14 💬
9GILENYA - 0.25 MG - CAPSULE RIGIDE - USO ORALE1件: Fingolimod (Gilenya)1件: Fingolimod (Gilenya (TN)) 💬 1件: S1PR1 💬 3件: FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬1件: 13 💬
10GILENYA - 0.5 MG - CAPSULE RIGIDE - USO ORALE1件: Fingolimod (Gilenya)1件: Fingolimod (Gilenya (TN)) 💬 1件: S1PR1 💬 3件: FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬1件: 13 💬
11GILENYA - 0.5 MG - CAPSULE RIGIDE - USO ORALE - BLISTER DIVISIBILE PER DOSE UNITARIA(PVC/PVDC/ALU) SCATOLA DA 7X1 CAPSULE1件: Fingolimod (Gilenya)1件: Fingolimod (Gilenya (TN)) 💬 1件: S1PR1 💬 3件: FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬1件: 13 💬
12GILENYA - 0.5 MG - CAPSULE RIGIDE - USO ORALE - BLISTER(PVC/PVDC/ALU) SCATOLA DA 28 CAPSULE1件: Fingolimod (Gilenya)1件: Fingolimod (Gilenya (TN)) 💬 1件: S1PR1 💬 3件: FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬1件: 13 💬
13Gilenya / Imusera1件: Fingolimod (Gilenya)1件: Fingolimod (Gilenya (TN)) 💬 1件: S1PR1 💬 3件: FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬1件: 13 💬
14GILENYA 0,5 mg cápsulas duras1件: Fingolimod (Gilenya)1件: Fingolimod (Gilenya (TN)) 💬 1件: S1PR1 💬 3件: FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬1件: 14 💬
15Gilenya 0,5 mg Hartkapseln1件: Fingolimod (Gilenya)1件: Fingolimod (Gilenya (TN)) 💬 1件: S1PR1 💬 3件: FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬1件: 13 💬
16Gilenya®1件: Fingolimod (Gilenya)1件: Fingolimod (Gilenya (TN)) 💬 1件: S1PR1 💬 3件: FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬1件: 13 💬
17Hidrocloruro de fingolimod
(Gilenya (TN))		1件: Fingolimod (Gilenya)1件: Fingolimod (Gilenya (TN)) 💬 1件: S1PR1 💬 3件: FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬2件: 13, 14 💬
18Interferons, glatiramer acetate, teriflunomide, dimethyl fumarate, alemtuzumab, cladribine, fingolimod, ponesimod, rituximab, ocrelizumab, ofatumumab, natalizumab
(Gilenya (TN))		12件: Acetate,
Alemtuzumab,
Cladribine,
Dimethyl fumarate,
Fingolimod (Gilenya),
Glatiramer,
Natalizumab,
Ocrelizumab,
Ofatumumab,
Ponesimod,
Rituximab,
Teriflunomide		10件: Cladribine ,
Alemtuzumab ,
Rituximab ,
Dimethyl fumarate ,
Ocrelizumab ,
Natalizumab ,
Ofatumumab ,
Fingolimod (Gilenya (TN)),
Teriflunomide ,
Ponesimod 💬 		7件: CD52,
DHODH,
ITGA4,
KEAP1,
MS4A1,
RRM1,
S1PR1 💬 		30件: Arrhythmogenic right ventricular cardiomyopathy, Biosynthesis of cofactors, Cell adhesion molecules, Chemical carcinogenesis - reactive oxygen species, Dilated cardiomyopathy, Drug metabolism - other enzymes, ECM-receptor interaction, Fluid shear stress and atherosclerosis, Focal adhesion, FoxO signaling pathway, Glutathione metabolism, Hematopoietic cell lineage, Hepatocellular carcinoma, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, Metabolic pathways, Neuroactive ligand-receptor interaction, Nucleotide metabolism, PI3K-Akt signaling pathway, Parkinson disease, Pathways in cancer, Purine metabolism, Pyrimidine metabolism, Regulation of actin cytoskeleton, Sphingolipid signaling pathway, Ubiquitin mediated proteolysis, Yersinia infection 💬1件: 13 💬
19Verum arm receiving Gilenya®----1件: 13 💬